Kiniksa Pharmaceuticals International, plc Cash and Cash Equivalents
Kiniksa Pharmaceuticals International, plc (KNSA) had Cash and Cash Equivalents of $189.95 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-04-28
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $189.95M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $165.60M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $174.86M.
- 2025-06-30: Cash and Cash Equivalents, at Carrying Value $192.04M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-03-31 | $189.95M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $165.60M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $174.86M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $192.04M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $157.13M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $183.58M 10-K · filed 2026-02-24 |
| 2024-09-30 | $97.38M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $99.27M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $141.08M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $107.95M 10-K · filed 2025-02-25 |
| 2023-09-30 | $117.83M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $112.57M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $80.62M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $122.72M 10-K · filed 2024-02-28 |
| 2022-09-30 | $175.76M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $94.31M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $63.32M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $122.47M 10-K · filed 2023-03-02 |
| 2021-09-30 | $190.18M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $167.95M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $119.86M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $114.04M 10-K · filed 2022-02-24 |
| 2020-09-30 | $85.87M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $123.46M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $106.34M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $46.93M 10-K · filed 2021-02-25 |
| 2019-09-30 | $68.81M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $82.81M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $82.63M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $71.98M 10-K · filed 2020-03-05 |
| 2018-09-30 | $69.66M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $285.52M 10-Q · filed 2018-08-06 |
| 2017-12-31 | $45.55M 10-K · filed 2019-03-12 |